Skip to main content
Caplight Logo









Madera Therapeutics

Madera Therapeutics

Private
Cary, North CarolinaHealthcare & Life Scienceshttps://maderat.com/

Company Overview

Madera Therapeutics is a biotechnology company that develops small molecule therapeutics targeting mitochondrial proteases for the treatment of cancer.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

small-molecule therapeuticsoncologydrug discoverymitochondrial proteaseClpP agonistbiotechcancer researchdrug-resistant cancerhedgehog inhibitorpreclinical developmentmitochondrial metabolismdrug pipelinebiotech startuptherapeutic development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Madera Therapeutics Comparables

Compare Madera Therapeutics with similar companies based on industry and business-model similarity.

Madera Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cryton Biosciences
78%
BPGbio, Inc.
77%
Bantam Pharmaceutical
75%

Madera Therapeutics Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Madera Therapeutics Filings

Explore SEC and related filing metadata, where available.

Madera Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Madera Therapeutics's valuation, stock price, and market status.

Is Madera Therapeutics a public or private company?

Madera Therapeutics is a private company.

What is the current stock price of Madera Therapeutics?

Madera Therapeutics is a private company with no public stock price. No recent secondary market data is available.

How much is Madera Therapeutics worth (valuation)?

Valuation information for Madera Therapeutics is not publicly available.

Can I buy Madera Therapeutics stock?

Madera Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Madera Therapeutics's last funding round?

Funding round information for Madera Therapeutics is not publicly available.

Who are the main investors in Madera Therapeutics?

Investor information for Madera Therapeutics is not publicly disclosed.

Will Madera Therapeutics IPO soon?

No public IPO plans have been announced for Madera Therapeutics.

How can I track Madera Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Madera Therapeutics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCary, North Carolina
Employee Range2
Year FoundedN/A
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?